title: Class I and Class II Lanthipeptides Produced by Bacillus spp.
abstract: The increasing number of multidrug-resistant pathogens, along with the small number of new antimicrobials under development, leads to an increased need for novel alternatives. Class I and class II lanthipeptides (also known as lantibiotics) have been considered promising alternatives to classical antibiotics. In addition to their relevant medical applications, they are used as probiotics, prophylactics, preservatives, and additives in cosmetics and personal-care products. The genus Bacillus is a prolific source of bioactive compounds including ribosomally and nonribosomally synthesized antibacterial peptides. Accordingly, there is significant interest in the biotechnological potential of members of the genus Bacillus as producers of antimicrobial lanthipeptides. The present review focuses on aspects of the biosynthesis, gene cluster organization, structure, antibacterial spectrum, and bioengineering approaches of lanthipeptides produced by Bacillus strains. Their efficacy and potency against some clinically relevant strains, including MRSA and VRE, are also discussed. Although no lanthipeptides are currently in clinical use, the information herein highlights the potential of these compounds.
authors.affiliation: Department of Biology & Centre for Environmental and Marine Studies (CESAM), University of Aveiro , 3810-193 Aveiro, Portugal.
authors.forename: Joana
authors.initials: J
authors.lastname: Barbosa
authors.affiliation: Department of Biology & Centre for Environmental and Marine Studies (CESAM), University of Aveiro , 3810-193 Aveiro, Portugal.
authors.forename: Tânia
authors.initials: T
authors.lastname: Caetano
authors.affiliation: Department of Biology & Centre for Environmental and Marine Studies (CESAM), University of Aveiro , 3810-193 Aveiro, Portugal.
authors.forename: Sónia
authors.initials: S
authors.lastname: Mendo
mesh_terms: D000595:Amino Acid Sequence; D000818:Animals; D000900:Anti-Bacterial Agents / Q000737:chemistry / Q000145:classification / Q000302:isolation & purification / Q000494:pharmacology; D001407:Bacillus / Q000737:chemistry* / Q000235:genetics; D001430:Bacteriocins / Q000737:chemistry / Q000145:classification / Q000302:isolation & purification / Q000494:pharmacology; D055624:Methicillin-Resistant Staphylococcus aureus / Q000187:drug effects; D015394:Molecular Structure; D005810:Multigene Family; D010455:Peptides / Q000737:chemistry / Q000145:classification / Q000302:isolation & purification / Q000494:pharmacology
chemical_list: D000900:Anti-Bacterial Agents; D001430:Bacteriocins; D010455:Peptides